Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Emily F. Dunn"'
Autor:
Jeffrey V. Brower, MD, PhD, Sylvia S. Rhodes, BA, Jill S. Remick, MD, Andrea L. Russo, MD, Emily F. Dunn, MD, Diandra N. Ayala-Peacock, MD, Daniel G. Petereit, MD, Kristin A. Bradley, MD, Neil K. Taunk, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 4, Pp 101188- (2023)
Purpose: The COVID-19 pandemic has placed demands and limitations on the delivery of health care. We sought to assess the effect of COVID-19 on the delivery of gynecologic oncologic care from the perspective of practicing radiation oncologists in the
Externí odkaz:
https://doaj.org/article/bd62e4f6559c4b90b229babbaa4d6019
Autor:
Emily F. Dunn, MD, Adil Akhtar, ME, Adam Dunn, MSEd, Scott Lacey, PhD, Ethan Pauley, BA, Colton Powers, BS, James McKee, MS, Daniel Petereit, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 2, Pp 100636- (2021)
Purpose: The supply of N95 masks and filtering facepiece respirators (FFRs) has been limited nationally owing to the coronavirus disease 2019 pandemic. Ultraviolet C (UVC) light has been suggested as a potential option for decontamination of FFRs by
Externí odkaz:
https://doaj.org/article/3a46e68fa63f4061aa153d7e2d4659f2
Autor:
Deric L. Wheeler, Ravi Salgia, Kari B. Wisinski, David Yang, Matthew J. Wleklinski, Kelsey L. Corrigan, Kellie T. Kostopoulos, Neha Luthar, Emily F. Dunn, Mari Iida, Toni M. Brand
PDF - 3969K, Supplemental Figure 1. Therapeutic inhibition of SFKs can block nEGFR translocation in colorectal tumor models.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d3c68d43f02642b37d7b611c071ee1e
https://doi.org/10.1158/1535-7163.22500735
https://doi.org/10.1158/1535-7163.22500735
Autor:
Deric L. Wheeler, Ravi Salgia, Kari B. Wisinski, David Yang, Matthew J. Wleklinski, Kelsey L. Corrigan, Kellie T. Kostopoulos, Neha Luthar, Emily F. Dunn, Mari Iida, Toni M. Brand
PDF - 69K, Legend for Supplementary Figure 1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::356c87b12aea6ab844b4eb1744aed259
https://doi.org/10.1158/1535-7163.22500732
https://doi.org/10.1158/1535-7163.22500732
Autor:
Emma C. Fields, Brandon A. Dyer, Matthew M. Harkenrider, Jenna M. Kahn, Emily F. Dunn, Ramesh Rengan, Daniel G. Petereit, Junzo Chino, Vonetta M. Williams, Jyoti Mayadev, L. Christine Fang, Jonathan M. Chen
Publikováno v:
Brachytherapy
Purpose The purpose of this study was to highlight the importance of timely brachytherapy treatment for patients with gynecologic, breast, and prostate malignancies, and provide a framework for brachytherapy clinical practice and management in respon
Autor:
Ethan, Pauley, Colton, Powers, Doug, Koch, David, Ellenbecker, Richard, Crilly, James, McKee, Adil, Akhtar, Scott, Piebenga, Daniel, Petereit, Emily F, Dunn
Publikováno v:
South Dakota medicine : the journal of the South Dakota State Medical Association. 73(5)
Autor:
James McKee, Scott Lacey, Emily F. Dunn, Colton Powers, Adam Dunn, Daniel G. Petereit, Ethan Pauley, Adil Akhtar
Publikováno v:
Advances in Radiation Oncology
Advances in Radiation Oncology, Vol 6, Iss 2, Pp 100636-(2021)
Advances in Radiation Oncology, Vol 6, Iss 2, Pp 100636-(2021)
Purpose: The supply of N95 masks and filtering facepiece respirators (FFRs) has been limited nationally owing to the coronavirus disease 2019 pandemic. Ultraviolet C (UVC) light has been suggested as a potential option for decontamination of FFRs by
Autor:
Deric L. Wheeler, David T. Yang, Kellie T. Kostopoulos, Mari Iida, Emily F. Dunn, Neha Luthar, Toni M. Brand, Matthew J. Wleklinski, Kelsey L. Corrigan, Kari B. Wisinski, Ravi Salgia
Publikováno v:
Molecular Cancer Therapeutics. 13:1356-1368
Triple-negative breast cancer (TNBC) is a subclass of breast cancers (i.e., estrogen receptor–negative, progesterone receptor–negative, and HER2-negative) that have poor prognosis and very few identified molecular targets. Strikingly, a high perc
Autor:
Toni M, Brand, Mari, Iida, Emily F, Dunn, Neha, Luthar, Kellie T, Kostopoulos, Kelsey L, Corrigan, Matthew J, Wleklinski, David, Yang, Kari B, Wisinski, Ravi, Salgia, Deric L, Wheeler
Publikováno v:
Molecular Cancer Therapeutics. 18:868-868
Triple-negative breast cancer (TNBC) is a subclass of breast cancers (i.e. estrogen receptor negative, progesterone receptor negative, and HER2 negative) that have poor prognosis and very few identified molecular targets. Strikingly, a high percentag
Autor:
Chunrong Li, Toni M. Brand, Mari Iida, Chimera R. Peet, Rebecca A. Myers, Deric L. Wheeler, Kellie T. Kostopoulos, Emily F. Dunn
Publikováno v:
Cancer Biology & Therapy. 12:436-446
The epidermal growth factor receptor (EGFR) is a ubiquitously expressed receptor tyrosine kinase (RTK) and is recognized as a key mediator of tumorigenesis in many human tumors. Currently there are five EGFR inhibitors used in oncology, two monoclona